Lenvatinib prolongs the progression-free survival time of patients with intermediate-stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis

Tyrosine kinase inhibitors are considered for use in patients with hepatocellular carcinoma (HCC) refractory to transarterial chemoembolization (TACE). The aim of the present retrospective study was to identify factors associated with progression-free survival (PFS) and to evaluate the indications f...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncol Lett
Main Authors: Shimose, Shigeo, Kawaguchi, Takumi, Tanaka, Masatoshi, Iwamoto, Hideki, Miyazaki, Ken, Moriyama, Etsuko, Suzuki, Hiroyuki, Niizeki, Takashi, Shirono, Tomotake, Nakano, Masahito, Suga, Hideya, Yamaguchi, Taizo, Yokokura, Yoshinori, Noguchi, Kazunori, Koga, Hironori, Torimura, Takuji
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2020
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7400966/
https://ncbi.nlm.nih.gov/pubmed/32782543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11758
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker